Nascent Biotech, Inc. (NBIO)
USD 0.06
(16.67%)
USD 0.06
(16.67%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1 Million | 750 Thousand | - | - |
| Cost of Revenue | 319.5 Thousand | - | - | - | - | - |
| Gross Profit | -319.5 Thousand | - | 1 Million | 750 Thousand | - | - |
| Operating Expenses | 2.22 Million | 2.14 Million | 1.45 Million | 2.15 Million | 3.44 Million | 1.36 Million |
| Selling, General and Administrative Expenses | 1.7 Million | 1.48 Million | 927.35 Thousand | 1.82 Million | 3.15 Million | 1.11 Million |
| Research and Development Expenses | 203.44 Thousand | 270.52 Thousand | 197.4 Thousand | 321.93 Thousand | 293.7 Thousand | 254 Thousand |
| Other Expenses | - | 1.49 Million | 332.28 Thousand | -369.00 | - | - |
| Cost and Expenses | 2.22 Million | 2.14 Million | 1.45 Million | 2.15 Million | 3.44 Million | 1.36 Million |
| Operating Income | -2.22 Million | -2.15 Million | -457.05 Thousand | -1.4 Million | -3.44 Million | -1.36 Million |
| Interest Expense | 379.97 Thousand | 1.72 Million | 336.02 Thousand | 336.63 Thousand | 86.63 Thousand | - |
| Income Tax Expense | - | 2.21 Million | -322.68 Thousand | 356.04 Thousand | 86.62 Thousand | -41.00 |
| Earnings before Tax | -2.08 Million | -2.8 Million | -470.39 Thousand | -958.76 Thousand | -4 Million | -1.36 Million |
| Net Income | -2.08 Million | -2.8 Million | -147.7 Thousand | -1.31 Million | -4.09 Million | -1.36 Million |
| Earnings Per Share Basic | -0.01 | -0.02 | -0.00 | -0.02 | -0.12 | -0.05 |
| Earnings Per Share Diluted | -0.01 | -0.02 | -0.00 | -0.02 | -0.12 | -0.05 |
| Weighted Average Shares Outstanding | 155.75 Million | 118.56 Million | 107.74 Million | 72.34 Million | 34.39 Million | 30.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 155.74 Million | 118.56 Million | 107.74 Million | 72.34 Million | 34.39 Million | 30.09 Million |
| Gross Margin | - | - | 1.00 | 1.00 | - | - |
| EBIT Margin | - | - | -0.61 | -1.89 | - | - |
| Profit Margin | - | - | -0.15 | -1.75 | - | - |
| EBITDA | 527.43 Thousand | - | -134.4 Thousand | - | -470.21 Thousand | 41.00 |
| Earnings Before Tax Margin | - | - | -0.46 | -1.87 | - | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | 3.38 | - | - | - | - |
| Cost of Revenue | 319.5 Thousand | 181.31 Thousand | 1.69 | - | - | - |
| Gross Profit | -319.5 Thousand | -181.3 Thousand | -1.69 | - | - | - |
| Operating Expenses | 2.22 Million | 516.02 Thousand | 364.42 Thousand | 837.45 Thousand | 511.97 Thousand | 524.29 Thousand |
| Selling, General and Administrative Expenses | - | 496.44 Thousand | 298.15 Thousand | 778.22 Thousand | 317.11 Thousand | 277.73 Thousand |
| Research and Development Expenses | - | 19.58 Thousand | 66.27 Thousand | 28.3 Thousand | 25.91 Thousand | 82.02 Thousand |
| Other Expenses | 1.71 Million | 1.71 Million | - | - | - | 1.27 Million |
| Cost and Expenses | 2.22 Million | 516.02 Thousand | 364.42 Thousand | 837.45 Thousand | 511.97 Thousand | 524.29 Thousand |
| Operating Income | -2.22 Million | -516.03 Thousand | -364.42 Thousand | -837.45 Thousand | -511.97 Thousand | -539.82 Thousand |
| Interest Expense | -385.23 Thousand | 22.5 Thousand | 24.89 Thousand | 125.12 Thousand | 237.71 Thousand | 399.02 Thousand |
| Income Tax Expense | -2.22 Million | -516.02 Thousand | -364.42 | 124.75 Thousand | 237.69 Thousand | -514.35 Thousand |
| Earnings before Tax | -2.08 Million | -512.57 Thousand | -205.4 Thousand | -829.47 Thousand | -540.22 Thousand | -518.05 Thousand |
| Net Income | -2.08 Million | -512.57 Thousand | -205.4 Thousand | -829.47 Thousand | -540.22 Thousand | -518.05 Thousand |
| Earnings Per Share Basic | - | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 155.74 Million | 170.59 Million | 167.24 Million | 148.47 Million | 139.95 Million | 131.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 155.74 Million | 170.59 Million | 167.24 Million | 148.47 Million | 139.95 Million | 131.76 Million |
| Gross Margin | - | -53.7 Thousand | - | - | - | - |
| EBIT Margin | - | -152.85 Thousand | - | - | - | - |
| Profit Margin | - | -151.82 Thousand | - | - | - | - |
| EBITDA | - | -516.03 Thousand | -364.42 Thousand | -837.08 Thousand | -511.95 Thousand | -539.7 Thousand |
| Earnings Before Tax Margin | - | -152.85 Thousand | - | - | - | - |
LAB
3419
6904
600903
AAPT
MHM